BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30521973)

  • 1. Loss of Enzyme Activity in Mutated B4GALNT1 Gene Products in Patients with Hereditary Spastic Paraplegia Results in Relatively Mild Neurological Disorders: Similarity with Phenotypes of B4galnt1 Knockout Mice.
    Bhuiyan RH; Ohmi Y; Ohkawa Y; Zhang P; Takano M; Hashimoto N; Okajima T; Furukawa K; Furukawa K
    Neuroscience; 2019 Jan; 397():94-106. PubMed ID: 30521973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycosides are efficient reagents to induce readthrough of premature termination codon in mutant B4GALNT1 genes found in families of hereditary spastic paraplegia.
    Yesmin F; Bhuiyan RH; Ohmi Y; Ohkawa Y; Tajima O; Okajima T; Furukawa K; Furukawa K
    J Biochem; 2020 Aug; 168(2):103-112. PubMed ID: 32282910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
    Trinchera M; Parini R; Indellicato R; Domenighini R; dall'Olio F
    Mol Genet Metab; 2018 Aug; 124(4):230-237. PubMed ID: 29983310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural annotation of Beta-1,4-N-acetyl galactosaminyltransferase 1 (B4GALNT1) causing Hereditary Spastic Paraplegia 26.
    Dad R; Malik U; Javed A; Minassian BA; Hassan MJ
    Gene; 2017 Aug; 626():258-263. PubMed ID: 28536081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.
    Alecu JE; Ohmi Y; Bhuiyan RH; Inamori KI; Nitta T; Saffari A; Jumo H; Ziegler M; de Gusmao CM; Sharma N; Ohno S; Manabe N; Yamaguchi Y; Kambe M; Furukawa K; Sahin M; Inokuchi JI; Furakawa K; Ebrahimi-Fakhari D
    Am J Med Genet A; 2022 Sep; 188(9):2590-2598. PubMed ID: 35775650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis.
    Harlalka GV; Lehman A; Chioza B; Baple EL; Maroofian R; Cross H; Sreekantan-Nair A; Priestman DA; Al-Turki S; McEntagart ME; Proukakis C; Royle L; Kozak RP; Bastaki L; Patton M; Wagner K; Coblentz R; Price J; Mezei M; Schlade-Bartusiak K; Platt FM; Hurles ME; Crosby AH
    Brain; 2013 Dec; 136(Pt 12):3618-24. PubMed ID: 24103911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia.
    Wakil SM; Monies DM; Ramzan K; Hagos S; Bastaki L; Meyer BF; Bohlega S
    Clin Genet; 2014 Nov; 86(5):500-1. PubMed ID: 24283893
    [No Abstract]   [Full Text] [Related]  

  • 8. Homozygous B4GALNT1 mutation and biochemical glutaric acidemia type II: A case report.
    Rose L; Hall K; Tang S; Hasadsri L; Kimonis V
    Clin Neurol Neurosurg; 2020 Feb; 189():105553. PubMed ID: 31812852
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46).
    Sultana S; Reichbauer J; Schüle R; Mochel F; Synofzik M; van der Spoel AC
    Biochem Biophys Res Commun; 2015 Sep; 465(1):35-40. PubMed ID: 26220345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.
    Boukhris A; Schule R; Loureiro JL; Lourenço CM; Mundwiller E; Gonzalez MA; Charles P; Gauthier J; Rekik I; Acosta Lebrigio RF; Gaussen M; Speziani F; Ferbert A; Feki I; Caballero-Oteyza A; Dionne-Laporte A; Amri M; Noreau A; Forlani S; Cruz VT; Mochel F; Coutinho P; Dion P; Mhiri C; Schols L; Pouget J; Darios F; Rouleau GA; Marques W; Brice A; Durr A; Zuchner S; Stevanin G
    Am J Hum Genet; 2013 Jul; 93(1):118-23. PubMed ID: 23746551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2.
    Yoshida H; Koodie L; Jacobsen K; Hanzawa K; Miyamoto Y; Yamamoto M
    Sci Rep; 2020 Jan; 10(1):1199. PubMed ID: 31988291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DDHD2, whose mutation causes spastic paraplegia, promotes reactive oxygen species generation and apoptosis.
    Maruyama T; Baba T; Maemoto Y; Hara-Miyauchi C; Hasegawa-Ogawa M; Okano HJ; Enda Y; Matsumoto K; Arimitsu N; Nakao K; Hamamoto H; Sekimizu K; Ohto-Nakanishi T; Nakanishi H; Tokuyama T; Yanagi S; Tagaya M; Tani K
    Cell Death Dis; 2018 Jul; 9(8):797. PubMed ID: 30038238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.
    Nielsen JE; Johnsen B; Koefoed P; Scheuer KH; Grønbech-Jensen M; Law I; Krabbe K; Nørremølle A; Eiberg H; Søndergård H; Dam M; Rehfeld JF; Krarup C; Paulson OB; Hasholt L; Sørensen SA
    Eur J Neurol; 2004 Dec; 11(12):817-24. PubMed ID: 15667412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A founder mutation p.H701P identified as a major cause of SPG7 in Norway.
    Rydning SL; Wedding IM; Koht J; Chawla M; Øye AM; Sheng Y; Vigeland MD; Selmer KK; Tallaksen CM
    Eur J Neurol; 2016 Apr; 23(4):763-71. PubMed ID: 26756429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
    Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
    Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
    Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
    Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
    Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
    J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary spastic paraplegia type 35 caused by a novel FA2H mutation.
    Bektaş G; Yeşil G; Yıldız EP; Aydınlı N; Çalışkan M; Özmen M
    Turk J Pediatr; 2017; 59(3):329-334. PubMed ID: 29376581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic morphology and spine density is not altered in motor cortex and dentate granular cells in mice lacking the ganglioside biosynthetic gene B4galnt1 - A quantitative Golgi cox study.
    Dobrović B; Curić G; Petanjek Z; Heffer M
    Coll Antropol; 2011 Jan; 35 Suppl 1():25-30. PubMed ID: 21648307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.